drugset / Trial / NCT00652002

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5

NCT00652002

Phase 3 Completed 450 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare Symbicort with budesonide alone and with formoterol alone in the treatment of asthma in adolescents and adults

Timeline

Start
2002-07
Primary completion
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 320 ug Inhaled
Comparator Formoterol Other / unclassified 9 ug Inhaled
Subject budesonide/formoterol Unknown Inhaled

Indications